Amgen cuts price of cholesterol drug by almost 60%, echoing rival's move

Biotech giant Amgen is lowering the price of its cholesterol medicine Repatha by almost 60 percent, following a similar move from its competitor, after both drugs failed to meet sales expectations.

from Health and Science https://ift.tt/2z1oD76